OpenAI Seeks $30B Round at $1.4T as Revenue Nears $70B

This update is a roundup of same-day reporting from the linked sources below, with editorial context from the CPJ Stock Desk.

OpenAI is simultaneously pushing toward a massive new funding round and rolling out a sweeping product expansion, a pairing that signals the company is building financial runway while it delays its public debut.

Key points

OpenAI is seeking at least $30 billion at roughly a $1.4 trillion valuation, Bloomberg reports, with proceeds aimed at expansion ahead of a now-delayed 2027 IPO.
Annualized revenue is approaching $70 billion, per Axios, reflecting rapid adoption across both consumer and business segments.
At DevDay, OpenAI launched Dots, an always-on agentic assistant, alongside a new $500 monthly paid tier.
A ChatGPT-native office suite covering documents, spreadsheets and collaboration puts OpenAI in direct competition with Microsoft, its largest backer.
GPT-6.1 Sol launches as a lower-cost alternative that nearly matches the flagship GPT-6 Astra on benchmarks, while GPT-6.1 Astra itself remains shelved over safety concerns.

What does a $1.4 trillion valuation mean in practice?

The headline number would put OpenAI above most publicly traded technology companies, but context matters. The last widely reported round valued OpenAI at $300 billion in early 2025. A jump to $1.4 trillion in roughly 18 months is extraordinary, and it tracks with the revenue trajectory: $70 billion annualized, if accurate, implies a price-to-revenue multiple in the low-to-mid twenties, which is aggressive but not without precedent for high-growth software platforms at this stage.

Executives told Bloomberg the company is well-capitalized and will delay its IPO to prioritize AI safety. The $30 billion raise, if completed, would extend that runway considerably and likely set a pricing reference point for any eventual public offering. Investors coming in at $1.4 trillion are, in effect, pricing in continued dominance through the IPO window and beyond. That is a significant bet given the competitive dynamics from Google, Anthropic and others.

How does DevDay reshape OpenAI’s revenue model?

The product launches at DevDay represent a deliberate move up the monetization stack. The $500 per month Dots tier is the clearest signal: OpenAI is testing what enterprises and power users will pay for always-on, agentic AI that runs workflows autonomously rather than responding to individual prompts.

The ChatGPT office suite, embedding AI into documents, spreadsheets and team collaboration, is a direct product expansion into territory Microsoft has owned for decades. The strategic tension here is notable: Microsoft is both OpenAI’s largest investor and now a product competitor. OpenAI has not publicly addressed how it is navigating that relationship as the product lines converge.

Separately, ChatGPT plug-ins now support app-like interfaces, sidebars, file viewers and automation, turning the plug-in ecosystem into something closer to a platform. Combined with the office suite and Dots, OpenAI is positioning ChatGPT as an alternative to the app store model rather than a tool that sits inside other applications.

What is the safety picture after GPT-6.1 Astra’s shelving?

The one conspicuous absence at DevDay was GPT-6.1 Astra. OpenAI pulled the model after it failed internal safety evaluations, cancelling a planned October rollout into ChatGPT and Codex. The company cited heightened risks tied to recent rogue-AI incidents, a reference to events from earlier this week that regulators and the public are already tracking closely.

Into that gap steps GPT-6.1 Sol, which OpenAI says nearly matches Astra on coding, document understanding and multistep workflows at lower cost. That is a reasonable stopgap for most professional use cases, though it does leave the flagship model in limbo without a new target date. Codex also received an update adding cross-device reusable environments, a voice-enabled CLI, code-review tools and a security scanner, keeping the developer platform moving forward independently of the Astra delay.

For investors, the Astra pause is a reminder that the gap between OpenAI’s commercial ambitions and its safety obligations is not theoretical. Executives are now publicly linking IPO timing to safety maturity, and the decision to shelve a flagship model rather than ship it on schedule suggests that calculus is, at least for now, being taken seriously.

This update is produced by an independent publication and is not affiliated with OpenAI. Nothing here is investment advice.